1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SMARCA4 CTRPv2 pan-cancer AAC 0.23 3e-11
mRNA ZNF439 CTRPv2 pan-cancer AAC 0.22 3e-11
mRNA FIZ1 CTRPv2 pan-cancer AAC 0.21 3e-11
mRNA FAM57B CTRPv2 pan-cancer AAC 0.22 3e-11
mRNA ZNF428 CTRPv2 pan-cancer AAC 0.22 3e-11
mRNA DNMT3A CTRPv2 pan-cancer AAC 0.22 4e-11
mRNA CDKN2D CTRPv2 pan-cancer AAC 0.21 4e-11
mRNA FBXO25 CTRPv2 pan-cancer AAC 0.21 4e-11
mRNA UNC5A CTRPv2 pan-cancer AAC 0.22 5e-11
mRNA ZNF397 CTRPv2 pan-cancer AAC 0.21 6e-11
Download CSV